|
original article |
Journal |
Date |
Title |
Authors All Authors |
1 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―May―04 |
Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study |
Joshua W. Bliss, Jessica A. Lavery, Whitney P. Underwood, Su S. Chun, Gina A. Fickera, Catherine P. Lee, et al. (+8) Stacie Corcoran, Molly A. Maloy, Fernanda C. Polubriaginof, Daniel W. Kelly, Jessica M. Scott, Paul C. Boutros, Chaya S. Moskowitz, Lee W. Jones |
2 |
[GO] |
Cancer Prevention Research |
2022―May―03 |
Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs |
Goli Samimi, Margaret House, Kelly Benante, Lisa Bengtson, Troy Budd, Bridget Dermody, et al. (+8) Katina DeShong, Valerie Dyer, Bruce F. Kimler, Vikrant V. Sahasrabuddhe, Suzanne Siminski, Leslie G. Ford, Eduardo Vilar, Eva Szabo |
3 |
[GO] |
Cancer Discovery |
2022―May―02 |
Top COVID-19 Prognostic Factors Identified |
|
4 |
[GO] |
Cancer Discovery |
2022―Apr―04 |
Vive la Résistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection |
Lisa H.F. McGary, Santosha A. Vardhana |
5 |
[GO] |
Blood Cancer Discovery |
2022―Mar―09 |
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysis |
Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, et al. (+54) Ruben A. Mesa, Sanjay Mishra, Daniel P. Mundt, Dimpy P. Shah, R. Alejandro Sica, Keith E. Stockerl-Goldstein, Catherine Stratton, Matthias Weiss, Alicia Beeghly-Fadiel, Melissa Accordino, Sarit E. Assouline, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Mehmet Asim. Bilen, Cecilia A. Castellano, Jacob C. Cogan, Devendra KC, Christopher R. Friese, Shilpa Gupta, Daniel Hausrath, Clara Hwang, Nathalie A. Johnson, Monika Joshi, Anup Kasi, Elizabeth J. Klein, Vadim S. Koshkin, Nicole M. Kuderer, Daniel H. Kwon, Chris Labaki, Tahir Latif, Eric Lau, Xuanyi Li, Gary H. Lyman, Rana R. McKay, Gayathri Nagaraj, Amanda Nizam, Taylor K. Nonato, Adam J. Olszewski, Hyma V. Polimera, Andrew J. Portuguese, Matthew M. Puc, Pedram Razavi, Rachel Rosovski, Andrew Schmidt, Sumit A. Shah, Aditi Shastri, Christopher Su, Pallawi Torka, Trisha M. Wise-Draper, Leyre Zubiri, Jeremy L. Warner, Michael A. Thompson |
6 |
[GO] |
Cancer Discovery |
2022―Mar―09 |
The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals. |
Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaelle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, et al. (+62) Damien Drubay, Carolina Alves Costa Silva, Lyon Covid Study Group, Eric de Sousa, Cassandra Thelemaque, Clea Melenotte, Agathe Dubuisson, Arthur Geraud, Gladys Ferrere, Roxanne Birebent, Camille Bigenwald, Marion Picard, Luigi Cerbone, Joana R. Lerias, Ariane Laparra, Alice Bernard-Tessier, Benoit Kloeckner, Marianne Gazzano, Francois-Xavier Danlos, Safae Terrisse, Eugenie Pizzato, Caroline Flament, Pierre Ly, Eric Tartour, Nadine Benhamouda, Lydia Meziani, Abdelhakim Ahmed-Belkacem, Makoto Miyara, Guy Gorochov, Fabrice Barlesi, Alexandre Trubert, Benjamin Ungar, Yeriel Estrada, Caroline Pradon, Emmanuelle Gallois, Fanny Pommeret, Emeline Colomba, Pernelle Lavaud, Marc Deloger, Nathalie Droin, Eric Deutsch, Bertrand Gachot, Jean-Philippe Spano, Mansouria Merad, Florian Scotte, Aurelien Marabelle, Frank Griscelli, Jean-Yves Blay, Jean-Charles Soria, Miriam Merad, Fabrice Andre, Juliette Villemonteix, Mathieu F. Chevalier, Sophie Caillat-Zucman, Florence Fenollar, Emma Guttman-Yassky, Odile Launay, Guido Kroemer, Bernard La Scola, Markus Maeurer, Lisa Derosa, Laurence Zitvogel |
7 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-12-09: Implications of protocol modifications and treatment delays for breast cancer patient experiences during Covid-19 |
Tamara Hamlish, Elizabeth L Papautsky |
8 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-01-12: The impact of COVID-19 on diagnosis of recurrent breast cancer |
Serena Di Cosimo, Catherine Depretto, Rosalba Miceli, Paolo Baili, Silva Ljevar, Milena Sant, et al. (+12) Claudio Ferranti, Secondo Folli, Massimiliano Gennaro, Filippo G de Braud, Claudio Vernieri, Maria Carmen De Santis, Laura Lozza, Andrea Vingiani, Giancarlo Pruneri, Giovanni Apolone, Alfonso Marchianò, Gianfranco P Scaperrotta |
9 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-11-08: Impact of COVID-19 on patients undergoing neoadjuvant therapy: A pre/post pandemic analysis and assessment of quality of care delivered |
Lauren Corke, Omar Hajjaj, Kaylie Willemsma, Stephen Chia, Christine Simmons |
10 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-10-05: The estimated impact of COVID-19 on population breast cancer screening outcomes, and options for risk-based recovery |
Pietro Procopio, Sabine Deij, Louiza S Velentzis, Amanda Tattam, Lara Petelin, Carolyn Nickson |
11 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the COVID-19 outbreak |
Sophie Martin, Carole Pflumio, Philippe Trensz, Frederique Schaff-Wendling, Michal Kalish, Cathie Fischbach, et al. (+4) Laure Pierard, Jean-Marc Limacher, Michel Velten, Thierry Petit |
12 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-12-37: The impact of the COVID-19 outbreak on breast cancer stage in the Netherlands by screening status |
Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Carla H van Gils, Marc BI Lobbes, Vivianne CG Tjan-Heijnen, et al. (+4) Luc JA Strobbe, Jelle Wesseling, Ruud M Pijnappel, Mireille JM Broeders |
13 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-12-09: Impact of the COVID-19 outbreak on the treatment strategy of Dutch breast cancer patients |
Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Desiree HJG van den Bongard, Willemien Menke-van der Houven van Oordt, Pieter J Westenend, et al. (+12) Ester JM Siemerink, Luc JA Strobbe, Marie-Jeanne TFD Vrancken Peeters, Linetta B Koppert, Marc AM Mureau, Agnes Jager, Mireille JM Broeders, Marc BI Lobbes, Helena M Verkooijen, Jelle Wesseling, Marjolein Smidt, Vivianne CG Tjan-Heijnen |
14 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-06: Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic |
Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi |
15 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-03: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic |
Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2) Melissa L Bondy, Allison W Kurian |
16 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic |
Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Thomas Wetzel, et al. (+2) Steve Power, Grace Campbell |
17 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-01: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic |
Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2) Melissa L Bondy, Allison W Kurian |
18 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-13-17: A phase III, randomized, multicenter, double-blind study to compare efficacy and safety of EG12014 (EirGenix trastuzumab) with Herceptin® as neoadjuvant treatment in combination with anthracycline/paclitaxel-based systemic therapy in patients with HER2-positive early breast cancer - a multinational phase III study conducted during the COVID-19 pandemic |
Barbara Grohmann-Izay, Chiun-Sheng Huang, Giorgi Dzagnidze, Nestor Llinas, Anand Misra, Denys Pominchuk, et al. (+6) Alexander Prokhorov, Bernardo Rapoport, Vladimir Semiglazov, Ling-Ming Tseng, Eduardo Yanez Ruiz, Sibylle Loibl |
19 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-04-04: Multi-institutional perspective on screening mammography and breast cancer stage at diagnosis during the COVID-19 pandemic |
Sarah J Stephens, Maxwell R Lloyd, Julian C Hong, Tejas Mehta, Ted A James, Rachel Blitzblau, et al. (+2) Abram Recht, Daphna Y Spiegel |
20 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-23-04: A comprehensive, multidisciplinary approach to breast cancer treatment during the COVID-19 pandemic improves time to treatment |
Amila Orucevic, Robin Hutson, Robert Heidel, Jillian Lloyd, Garnetta Morin-Ducote, Christine Lauro, et al. (+5) Ellen Perkins, Timothy Panella, Lisa Duncan, Stuart VanMeter, John Bell |
21 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences |
Noura Alsafar, Desiree Hao, Nimira Alimohamed, Sunil Samnani, Sasha Lupichuk |
22 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications |
Hani Katerji, Huina Zhang, Xi Wang, Linda Schiffhauer, Ajay Dhakal, Alissa Huston, et al. (+3) Carla Falkson, David Hicks, Bradley Turner |
23 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination |
Kristin Robinson, Santo Maimone, Pooja P Advani, Zhuo Li, Denise Gococo-Benore, Neda Qosja, et al. (+8) Ashita Mummareddy, Ahmed M Ashai, Annamaria Wilhelm, Robert Maxwell, Martha Wasserman, Neema Patel, Andrey Morozov, Saranya Chumsri |
24 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P1-01-01: Prospective ultrasonographic surveillance study for incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy |
Kumiko Kida, Hiroko Tsunoda, Risa Kasahara, Chika Tsutsumi, Akiko Numata, Yuri Takehara, et al. (+5) Atsushi Yoshida, Junko Takei, Naoki Hayashi, Daiki Kobayashi, Hideko Yamauchi |
25 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-17: Declining the COVID-19 vaccination: An evaluation of why some high risk cancer patients decline vaccination |
Kate I Lathrop, Eva Prieto, Stefany Viveros, Salyna Riggs, Eva Balboa, Juanita Murray, et al. (+2) Cynthia Evans, Sukeshi Arora |
26 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-15-03: Neoadjuvant endocrine therapy (NET) as bridge therapy for early stage breast cancer during COVID-19: A single institution experience |
Julie Huang, Joshua Feinberg, Bahram Dabiri, Jordan Baum, Meredith Akerman, Anthony Pasquarella, et al. (+4) Abhinav Rohatgi, Shubhada Dhage, Amber Guth, Nina D'Abreo |
27 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-03-01: Changes in breast cancer presentation during Covid-19: Experience in an Urban Academic Center |
Amber Azniv Guth, Brian Diskin, Freya Schnabel, Nakisa Pourkey, Deborah Axelrod, Richard Shapiro |
28 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-20: Neoadjuvant endocrine therapy (NET) during COVID-19: Single institution survey of patients’ perspectives |
Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, et al. (+4) Jordan Baum, Shubhada Dhage, Amber Guth, Nina D'Abreo |
29 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients |
Saranya Chumsri, Pooja P. Advani, Tanmayi S Pai, Zhou Li, Marites Acampora, Gina A Reynolds, et al. (+3) Alvaro Moreno-Aspitia, Christopher P Marquez, Keith L. Knutson |
30 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer |
Cory Bivona, Kevin Li, Priyanka Sharma, Jianghua He, Grace Martin, Andrew K Godwin, et al. (+19) Anthony Rooney, Stephen Williamson, Gary Doolittle, Weijing Sun, Bruce F Kimler, Anne P O'Dea, Lauren E Nye, Joseph P McGuirk, Ziyan Pessetto, Lisa Haney, Nicole Balmaceda, Laura Mitchell, Karissa Finke, Maggie Nelson, Dinesh Pal Mudaranthakam, Natalie Streeter, Stephanie Lafaver, Jaimie Heldstab, Qamar J Khan |
31 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-23-02: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors |
Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Alejandro Balazs, Lindsey Mortensen, Elizabeth Niehoff, et al. (+11) Caroline Barabell, Jennifer A. Hutchinson, Seth A. Wander, Aron S. Rosenstock, Leif W. Ellisen, Beverly Moy, Steven J. Isakoff, Justin F. Gainor, A. John Iafrate, Aditya Bardia, Laura M. Spring |
32 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-11-02: Evaluation of the effects of anticancer treatments in cancer patients undergoing SARS-COV2 vaccination (VAX-on study: Breast cancer subgroup analysis) |
Agnese Fabbri, Eleonora Marrucci, Fabrizio Nelli, Marco Mazzotta, Angelo Onorato, Primi Francesca, et al. (+7) Mario Giovanni Chilelli, Antonella Virtuoso, Carlo Signorelli, Julio R Giron Berrios, Marta Schirripa, Rossella Donghia, Enzo Maria Ruggeri |
33 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction |
Gretchen Kimmick, Smrithi Davakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, et al. (+6) Susan Dent, Sarah Sammons, Jeremy Force, Kelly Westbrook, Carey Anders, Rebecca Shelby |
34 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-12-13: Psychosocial aspects in relation to clinical status of breast cancer patients after prolonged COVID pandemic in south India: A observational survey study |
Chandralekha Krishnan |
35 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-04: Changes in management of TNBC during the COVID19 pandemic of 2020 |
Dave Smart, Wendy L Allen, Raymond H Henderson, Susanne Munksted, Peter Riccelli |
36 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-17-06: Telephone triaging during the 1st wave of the COVID 19 Pandemic: Outcomes and proposed pathway for managing patients referred for breast pain |
Urvashi Jain, Robyn Coombe, Georgina Bitsakou, Ashutosh Kothari |
37 |
[GO] |
Clinical Cancer Research |
2022―Feb―09 |
AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care |
Patrick A. Williams, Sayyed Kaleem Zaidi, Rajarshi Sengupta |
38 |
[GO] |
Cancer Immunology Research |
2022―Jan―24 |
Immune-guided therapy of COVID-19 |
Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, et al. (+2) Stefania Canè, Vincenzo Bronte |
39 |
[GO] |
Cancer Discovery |
2021―Dec―22 |
Pandemic Provides Rapid Test of Telehealth |
|
40 |
[GO] |
Cancer Discovery |
2021―Dec―10 |
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer |
Arielle Elkrief, Julie T Wu, Chinmay Jani, Kyle T Enriquez, Michael Glover, Mansi R Shah, et al. (+13) Hira Ghazal Shaikh, Alicia Beeghly-Fadiel, Benjamin French, Sachin R Jhawar, Douglas B. Johnson, Rana R McKay, Donna R Rivera, Daniel Y Reuben, Surbhi Shah, Stacey L Tinianov, Donald Cuong Vinh, Sanjay Mishra, Jeremy L Warner |
41 |
[GO] |
Cancer Discovery |
2021―Dec―09 |
Navigating Cancer Care in the COVID-19 Era |
|
42 |
[GO] |
Cancer Research |
2021―Nov―10 |
Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients |
Jane C Figueiredo, Noah M Merin, Omid Hamid, So Yung Choi, Tucker Lemos, Wendy Cozen, et al. (+27) Nathalie Nguyen, Laurel J Finster, Joslyn Foley, Justin Darrah, Jun Gong, Ronald Paquette, Alain C Mita, Robert Vescio, Inderjit Mehmi, Reva Basho, Warren G Tourtellotte, Carissa A Huynh, Gil Y Melmed, Jonathan Braun, Dermot PB McGovern, Emebet Mengesha, Greg Botwin, John C Prostko, Edwin C Frias, James L Stewart, Sandy Joung, Jennifer Van Eyk, Joseph E Ebinger, Susan Cheng, Kimia Sobhani, Karen L Reckamp, Akil Merchant |
43 |
[GO] |
Cancer Discovery |
2021―Nov―09 |
Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies |
Christina Y. Lee, Monika K Shah, David Hoyos, Alexander Solovyov, Melanie Douglas, Ying Taur, et al. (+5) Peter Maslak, N Esther Babady, Benjamin Greenbaum, Mini Kamboj, Santosha A Vardhana |
44 |
[GO] |
Cancer Discovery |
2021―Oct―06 |
COVID-19 Use Causes Tocilizumab Shortage |
|
45 |
[GO] |
Cancer Prevention Research |
2021―Oct―04 |
Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies |
Ana Ribeiro, Flávia Corrêa, Arn Migowski, Aline Leal, Sandro Martins, Tainá Raiol, et al. (+8) Carla P. Marques, Katia L. Torres, Akiva P. Novetsky, Jenna Z. Marcus, Nicolas Wentzensen, Mark Schiffman, Ana Cecilia Rodriguez, Julia C. Gage |
46 |
[GO] |
Clinical Cancer Research |
2021―Sep―28 |
Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution. |
Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Vittoria Barberi, Maria Teresa Maccallini, Ludovica Gariazzo, et al. (+18) Martina Pontone, Alessandro Monti, Flaminia Campo, Emanuela Taraborelli, Maria Di Santo, Fabrizio Petrone, Chiara Mandoj, Virginia Ferraresi, Gianluigi Ferretti, Paolo Carlini, Ornella Di Bella, Laura Conti, Antonia Marina La Malfa, Raul Pellini, Domenico Bracco, Diana Giannarelli, Aldo Morrone, Francesco Cognetti |
47 |
[GO] |
Blood Cancer Discovery |
2021―Sep―15 |
How to provide the needed protection from COVID-19 to patients with hematologic malignancies |
Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, Faith E Davies, Steven D. Gore, Ronald Levy, Lee M Greenberger |
48 |
[GO] |
Blood Cancer Discovery |
2021―Sep―13 |
Disease and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies |
David J Chung, Gunjan L. Shah, Sean M. Devlin, Lakshmi V Ramanathan, Sital Doddi, Melissa S Pessin, et al. (+18) Elizabeth Hoover, LeeAnn T Marcello, Jennifer C Young, Sawsan R Boutemine, Edith Serrano, Saumya Sharan, Saddia Momotaj, Lauren Margetich, Christina D Bravo, Genovefa A Papanicolaou, Mini Kamboj, Anthony R. Mato, Lindsey E. Roeker, Malin Hultcrantz, Sham Mailankody, Alexander M Lesokhin, Santosha A Vardhana, David A Knorr |
49 |
[GO] |
Blood Cancer Discovery |
2021―Sep―13 |
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy |
Roni Tamari, Ioannis Politikos, David A Knorr, Santosha A Vardhana, Jennifer C Young, LeeAnn T Marcello, et al. (+12) Sital Doddi, Sean M. Devlin, Lakshmi V Ramanathan, Melissa S Pessin, Erica Dunn, Meighan Palazzo, Christina D Bravo, Genovefa A Papanicolaou, Mini Kamboj, Miguel-Angel Perales, David J Chung, Gunjan L. Shah |
50 |
[GO] |
Cancer Discovery |
2021―Sep―01 |
Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19? |
Bérengère Salomé, Amir Horowitz |
51 |
[GO] |
Cancer Discovery |
2021―Jul―21 |
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective |
Keith T. Flaherty, James H. Doroshow, Susan Galbraith, Antoni Ribas, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret |
52 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―16 |
Characteristics and outcomes of over 300,000 COVID-19 individuals with history of cancer in the United States and Spain |
Elena Roel, Andrea Pistillo, Martina Recalde, Anthony G Sena, Sergio Fernandez-Bertolin, Maria Aragon, et al. (+47) Diana Puente, Waheed-Ul-Rahman Ahmed, Heba Alghoul, Osaid Alser, Thamir M. Alshammari, Carlos Areia, Clair Blacketer, William Carter, Paula Casajust, Aedín C. Culhane, Dalia Dawoud, Frank DeFalco, Scott L DuVall, Thomas Falconer, Asieh Golozar, Mengchun Gong, Laura Hester, George Hripcsak, Eng Hooi Tan, Hokyun Jeon, Jitendra Jonnagaddala, Lana YH Lai, Kristine E Lynch, Michael E Matheny, Daniel R Morales, Karthik Natarajan, Fredrik Nyberg, Anna Ostropolets, Jose D Posada, Albert Prats-Uribe, Christian G Reich, Donna R Rivera, Lisa M Schilling, Isabelle Soerjomataram, Karishma Shah, Nigam H. Shah, Yang Shen, Matthew Spotnitz, Vignesh Subbian, Marc A Suchard, Annalisa Trama, Lin Zhang, Ying Zhang, Patrick B Ryan, Daniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles |
53 |
[GO] |
Cancer Discovery |
2021―Jul―16 |
Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine |
|
54 |
[GO] |
Cancer Discovery |
2021―Jul―07 |
COVID-19 Vaccines Complicate Breast Screening |
|
55 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―07 |
Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium |
Geert Silversmit, Freija Verdoodt, Nancy Van Damme, Harlinde De Schutter, Liesbet Van Eycken |
56 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 703: An inflammatory leptomeningeal signature in cancer patients with neurologic manifestations of COVID-19 |
Jessica A. Wilcox, Jan Remsik, N. Esther Babady, Tracy A. McMillen, Behroze A. Vachha, Neil A. Halpern, et al. (+6) Vikram Dhawan, Marc Rosenblum, Christine A. Iacobuzio-Donahue, Edward K. Avila, Bianca Santomasso, Adrienne Boire |
57 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 710: Androgen-deprivation therapy boosts MX1 expression, a silent effector against COVID-19 |
Juan Antonio Bizzotto, Pablo Sanchis, Sofia Lage-Vickers, Rosario Lavignolle, Agustina Sabater, Mercedes Abbate, et al. (+9) Ayelen Toro, Florencia Cascardo, Santiago Olszevicki, Nicolas Anselmino, Estefania Labanca, Emiliano Ortiz, Elba Vazquez, Javier Cotignola, Geraldine Gueron |
58 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19 |
Daniella Vaskovich-Koubi, Ron Kleiner, Yulia Liubomirski, Eilam Yeini, Galia Tiram, Sabina Pozzi, et al. (+3) Anat Eldar-Boock, Helena F. Florindo, Ronit Satchi-Fainaro |
59 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 704: Sex and age differences in telomere length and susceptibility to COVID-19 |
Manar Ahmed Kamal, Kareem Reda Alamiry, Mahmoud Zaki |
60 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 711: Repurposing 2nd generation androgen receptor antagonist Proxalutamide to treat COVID-19 |
Liandong Ma, Youzhi Tong, Qiang Guo, Yifeng Zhou, Qianxiang Zhou, Honghua Yan |
61 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 709: Estrogen and androgen receptor inhibitors: Unexpected allies in the fight against COVID-19 |
Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi, Davide Angeli, Giovanni Martinelli, Fabio Nicolini, et al. (+2) Paola Parrella, Massimiliano Mazza |
62 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 74: Stakeholder Selected Strategies to Improve Breast Cancer Care in East Africa: Preliminary Implementation Outcomes and Impact Of COVID-19 |
Anne Rositch, Christina Chao, Matogoro Kirahi, Nestory Masalu, Lucas Faustine, Leonard Washington Amango |
63 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 700: CellSig: A data-driven model of cytokine activity identifies therapeutic targets for severe COVID-19 and cancer immunotherapy-induced colitis |
Peng Jiang, Yu Zhang, Beibei Ru, Eytan Ruppin, Kai Wucherpfennig |
64 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 722: The hallmark of COVID-19 cancer disparities: Cellular sequelae |
Eva McGhee, Mengtao LI, Yi-Ling Lin, Nefertari Carr, Chinelo Njubigbo, Rohun Sadeghi, et al. (+6) Brooke Su-Velez, Julian Handler, Adin Handler, Judith Okoro, Sebhat Afework, Jay Vadgama |
65 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB076: Association between regional COVID-19 hospitalizations and treatment delays amongst confirmed cancer patients in England, UK |
Louis Fox, Ajay Aggarwal, Richard Sullivan, Kate Haire, Arnie Purushotham, James Spicer, et al. (+4) Sophie Papa, Anne Rigg, Saoirse Dolly, Mieke Van Hemelrijck |
66 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB074: Chymostatin, a cathepsin L inhibitor, inhibits lung cancer cell proliferation and COVID-19 Mpro in vitro |
Nagendra Sastry Yarla, Gopal Pathuri, Simon Terzyan, Yuting Zhang, Anil Singh, Marcus T. Scotti, et al. (+2) Venkateshwar Madka, Chinthalapally V. Rao |
67 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract CT201: Early report of a phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 (NCT04365101) |
Corey Casper, Leonid Groysman, Vinay Malhotra, Eric Whitman, Stacy Herb, Erica Rave, et al. (+17) Alan Lew, Cristina Goman, Zachary Sagawa, Monica Thakar, Victoria Lacasse, Cherie Daly, Shuyang He, Lin Kang, Sharmila Koppisetti, Tanel Mahlakõiv, Sunday Osokoya, William van der Touw, Junhong Zhu, Greg Berk, Xiaokui Zhang, Andrew Pecora, Robert Hariri |
68 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB073: The growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic |
Md Mohiuddin, Hideharu Kimura, Takashi Sone, Satoshi Watanabe, Hiroki Matsuoka, Keigo Saeki, et al. (+3) Nanao Terada, Miki Abo, Kazuo Kasahara |
69 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic |
Nathan W. Sweeney, Scott R. Goldsmith, Jennifer M. Ahlstrom |
70 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 719: The emergence of the COVID-19 pandemic and its impact on a novel cancer care delivery model at Federally Qualified Health Centers |
Nicolas Francone, Will Dunne, Jonathan Alhalel, Sankirtana Danner, Nihmotallahi Adebayo, T Madorsky, et al. (+6) Cassandra Osei, Juan Rivera, J Trossman, Christine Weldon, Elizabeth Adetoro, Melissa Simon |
71 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 11: Neglected Elements of Cancer Control During The COVID-19 Pandemic in Africa: Call for Action from 2019-2020 African Cancer Research and Control ECHO Programme |
Annet Nakaganda, Nwamaka Lasebikan, Elise M. Garton, Benda Kithaka, Mishka K. Cira |
72 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 31: Impact of the COVID-19 Pandemic on Cancer Registry Operations in the Caribbean |
Sarah Quesnel-Crooks, Rachel Hanisch, Isabelle Soerjomataram, Brenda Edwards, Arica White, Betsy Kohler, et al. (+3) Ann Chao, Les Mery, Glennis Andall-Brereton |
73 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 717: Rapid transformation of TTFields care-delivery during COVID-19 pandemic to optimize treatment of patients with glioblastoma (GBM) |
Peggy M. Frongillo, Melissa Shackelford, Lindsay Rain |
74 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 721: Early death in acute lymphoblastic leukemia during COVID-19 pandemic: A single institution cohort study |
Daniel J. Enriquez-Vera, Ali Al-kassab-Cordova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, Bryan Valcarcel, Cesar Samanez, et al. (+5) Juan Haro-Varas, Shirley Quintana-Truyenque, Luis Malpica, Henry Gomez-Leonidas, Tatiana Vidaurre-Rojas |
75 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 1162: Monitoring COVID-19 RNA methyltransferases activities for developing therapeutic drugs |
Said A. Goueli, Kevin Hsiao |
76 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 65: Early Assessment of the Pandemic Effects on Cancer Screening Services: The International Cancer Screening Network COVID-19 Survey |
Douglas M. Puricelli Perin, K. Miriam Elfström, Mireille J. M. Broeders |
77 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 715: Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model |
Xiaoshan Shi, Scott J. Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik |
78 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 18: Cancer Control Assessments in Low- and Middle-Income Countries during COVID-19: The IAEA-IARC-WHO imPACT Review Hybrid Modality |
Marianna Nobile, Kendall Siewert, Maria Tena Perpina, Yuliya Lyamzina |
79 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 712: Anticancer natural compounds as potential inhibitors of novel coronavirus (COVID19) main protease: An in-silico study |
Amaresh Mishra, Yamini Pathak, Gourav Choudhir, Anuj Kumar, Surabhi Kirti Mishra, Vishwas Tripathi |
80 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 706: Rapid detection of SARS-CoV-2 antigen and antibody seroconversion in clinical specimens using a novel Surface Programmable Activation Receptor (SPAR) modified T cell diagnostic method |
Aaron K. LeFebvre, Melissa Frenchmeyer, Kyle M. McQuaid, MRussell Williams, Charles M. McBrairty, Joseph D. Kittle |
81 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 713: Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs |
Rao V. Papineni, Amitava Adhikary, Ritesh Tandon, Dipanwita Mitra |
82 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 707: Detection of SARS-CoV-2 co-infections with seasonal respiratory viruses using a multiplexed amplicon NGS panel |
Lucie S. Lee, Rounak Feigelman, David Debruyne, Julia Spencer, Chenyu Li, Zhitong Liu, Guoying Liu |
83 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score |
Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44) Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher C. Sng, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Ricard Mesia, Ailsa Sita-Lumsden, Elia Seguí, Federica Biello, Daniele Generali, Salvatore Grisanti, Pavetha Seeva, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Charlotte Moss, Josep Tabernero, Beth Russell, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Raquel Liñan, Andrea Marrari, M. Carmen Carmona-García, Neha Chopra, Carlo Tondini, Oriol Mirallas, Valeria Tovazzi, Vittoria Fotia, Claudia Andrea Cruz, Nadia Saoudi-Gonzalez, Eudald Felip, Ariadna Roqué, Alvin J. Lee, Thomas Newsom-Davis, Andrea Patriarca, Lorenza Rimassa, Armando Santoro, Alessandra Gennari, Nikolaos Diamantis, David J. Pinato |
84 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 705: SARS-CoV-2 infection of the human heart governs intracardiac innate immune response |
Anthony W. Ashton, Liang Zhang, Yan Liang, Prajan Divakar, Carolos Cordon-Cardo, Richard G. Pestell |
85 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases |
Byoung S. Kwon, Seunghyun Lee, Jin-Kyung Choi, Bora Hwang, Sun-Woo Im, Yun-Sook Lim, et al. (+3) Bumseok Kim, Soon B. Hwang, HoonSung Jeh |
86 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus |
Zhiqiang Qin, Jungang Chen, Lu Dai, Lindsey Barrett, Steven Post |
87 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma |
Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, et al. (+25) Elena Bokatenkova, Beatriz Sanchez-Espiridion, Carmen Behrens, Luisa M. Solis, Boning Gao, Luc Girard, Jianjun Zhang, Boris Sepesi, Tina Cascone, Lauren A. Byers, Don L. Gibbons, Jichao Chen, Seyed Javad Moghaddam, Edwin J. Ostrin, Paul Scheet, Junya Fujimoto, Jerry Shay, John V. Heymach, John D. Minna, Steven Dubinett, Ignacio I. Wistuba, Christopher S. Stevenson, Avrum E. Spira, Linghua Wang, Humam Kadara |
88 |
[GO] |
Clinical Cancer Research |
2021―Jun―09 |
A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes |
David A. Potter, Alexandra Thomas, Hope S. Rugo |
89 |
[GO] |
Cancer Discovery |
2021―Jun―04 |
COVID-19 Reshapes Cancer Clinical Research |
|
90 |
[GO] |
Cancer Discovery |
2021―May―19 |
Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients |
Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S Heitmann, Marissa L Dubbelaar, et al. (+16) Andreas Peter, Sebastian Horber, Jens Bauer, Jonas Rieth, Marcel Wacker, Fiamma Berner, Lukas Flatz, Stefanie Held, Peter Brossart, Melanie Marklin, Philipp Wagner, Eva Erne, Reinhild Klein, Hans-Georg Rammensee, Helmut R Salih, Juliane S. Walz |
91 |
[GO] |
Cancer Discovery |
2021―May―14 |
Blood Cancers Diminish Response to COVID-19 Vaccine |
|
92 |
[GO] |
Cancer Prevention Research |
2021―Apr―28 |
Q&A: Ned Sharpless on COVID-19 and Cancer Prevention |
|
93 |
[GO] |
Cancer Discovery |
2021―Apr―12 |
Repurposing of anticancer drugs expands possibilities for antiviral and anti-inflammatory discovery in COVID-19 |
Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas, Jean-Charles Soria |
94 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Apr―02 |
Voices of Community Organizations: How Cancer Centers Can Support Communities in the Face of COVID-19 |
JD Austin, E Lee, RC Shelton, G Hillyer, K Schmitt, P Tehranifar |
95 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Apr―02 |
Financial and Employment Impacts of Cancer and COVID-19 Among African American Cancer Survivors |
TA Hastert, JJ Ruterbusch, AL Best, FWK Harper, H Thompson, JL Beebe-Dimmer, AG Schwartz |
96 |
[GO] |
Cancer Discovery |
2021―Apr―02 |
Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic |
Chris Labaki, Solange Peters, Toni K. Choueiri |
97 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Apr―02 |
Impact of COVID-19 Pandemic on Healthcare Delivery, Behavioral Outcomes, and Financial Stress in 1,253 Individuals with Cancer at Huntsman Cancer Institute (HCI) |
AR Peoples, C Himbert, CA Hathaway, AC Kirchhoff, J Ose, T Lin, et al. (+9) H Colman, KB Jones, WL Akerley, D Grossman, JP Hunt, FJ Penedo, EM Siegel, CM Ulrich, SS Tworoger |
98 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Apr―02 |
Improving Survey Response Rates Among Patients at a Cancer Center During a Global Pandemic |
CA Hathaway, EM Siegel, B Gonzalez, SS Tworoger |
99 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P30: Long-term outcomes of cancer patients infected with COVID-19 |
Justin Shaya, Angelo Cabal, Pedram Razavi, Rana R. McKay |
100 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P22: A high-throughput anti-SARS-CoV-2 IgG testing platform for COVID-19 |
Jinwei Du, Eric Chu, Dayu Zhang, Chuanyi M. Lu, Aiguo Zhang, Michael Sha |
101 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P08: Adenosine-based cancer immunotherapy for COVID-19 |
Giulia Monticone, Alistair Ramsay, Lucio Miele |
102 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P12: Colorectal cancer screening in Appalachian Kentucky primary care clinics during COVID-19 |
Aaron J. Kruse-Diehr, Mark Cromo, Melinda Rogers, Angela Carman, Bin Huang, David Gross, et al. (+3) Sue Russell, Vickie Fairchild, Mark Dignan |
103 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P41: Mental health and coping during COVID-19 among cancer patients and survivors |
Jeanine P.D. Guidry, Carrie A. Miller, Bernard F. Fuemmeler |
104 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City |
Monica F. Chen, Monica T. Coronel, Samuel Pan, Arreum Kim, Jessica Hawley, Gary Schwartz, Katherine Crew |
105 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy |
Justin A. Shaya, Angelo Cabal, Francesca Torriani, Joseph Califano, Scott Lippman, Assuntina Sacco, Rana R. McKay |
106 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy |
Sylvain Lamure, Remy Dulery, Marc Delord, Roberta Di Blasi, Adrien Chauchet, Thomas Hueso, et al. (+19) Cédric Rossi, Bernard Drenou, Bénédicte Deau-Fischer, Carole Soussain, Pierre Feugier, Nicolas Noel, Sylvain Choquet, Serge Bologna, Bertrand Joly, Laure Philippe, Milena Kohn, Sandra Malak, Guillemette Fouquet, Etienne Daguindau, Sophie Bernard, Yassine Taoufik, Karine Lacombe, Guillaume Cartron, Catherine Thieblemont |
107 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P24: Evidenced-based natural therapies and immune-enhancing strategies to control, prevent, and treat co-morbidities COVID-19 and cancer |
Padma P. T. Uppala, Sherri Isaak, Brian Wong, Kimberly Ferreira, Carlos Garberoglio, John Kelly |
108 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S06-02: Disruption to care of patients with thoracic malignancies: A COVID-19 and cancer outcomes study |
Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, John A. Steinharter, Douglas A. Tremblay, Mark M. Awad, et al. (+24) Alaina J. Kessler, Robert I. Haddad, Michelle Evans, Fiona Busser, Michael Wotman, Catherine R. Curran, Brittney S. Zimmerman, Gabrielle Bouchard, Tomi Jun, Pier V. Nuzzo, Qian Qin, Laure Hirsch, Jonathan Feld, Kaitlin M Kelleher, Danielle Seidman, Hsin-Hui Huang, Chris Labaki, Heather M. Anderson-Keightly, Sarah Abou Alaiwi, Talia D. Rosenbloom, Penina S. Stewart, Matthew D. Galsky, Toni K. Choueiri, Deborah B. Doroshow |
109 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P25: Prostate cancer and COVID-19 outcomes: Results from the Cleveland Clinic registry of COVID-19 and cancer patients |
Scott J. Dawsey, Nathan A. Pennell, Christopher Lemmon, Amanda Nizam, Wei Wei, Timothy D. Gilligan, et al. (+2) Moshe C. Ornstein, Shilpa Gupta |
110 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S11-04: Using CXR-Net to detect COVID-19 and non-COVID-19 patients |
Benjamen Huber, Abdulah Haikal, Domenico Gatti, Hamid Soltanian-Zadeh |
111 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S10-03: Adolescent and young adult cancer patient and survivor employment changes during COVID-19 are associated with financial toxicity |
Austin Waters, Heydon Kaddas, Karely Mann, Perla L. Vaca Lopez, Echo L. Warner, Joemy Ramsay, et al. (+9) Judy Ou, Nicole Ray, Tomoko Tsukamoto, Douglas B. Fair, Joseph M. Letourneau, Mark A. Lewis, David A. Gill, Lauri Linder, Anne C. Kirchhoff |
112 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P23: Detection of humoral and cellular responses to SARS-CoV-2 in COVID-19 convalescents |
Anna Baranska, Marc Schuster, Marek Wieczorek, Sebastian Flade, Lennart Wessels, Burhan Karaca, et al. (+3) Verena Traska, Mario Assenmacher, Gregor Winkels |
113 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 death |
Maria J. Monroy-Iglesias, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Sophie Papa, et al. (+35) Sheeba Irshad, Paul Ross, James Spicer, Sharam Kordasti, Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Rushan Sylva, Kamarul Zaki, Fareen Rahman, Ailsa Sita-Lumsden, Debra Josephs, Deborah Enting, Mary Lei, Sharmistha Ghosh, Claire Harrison, Angela Swampillai, Elinor Sawyer, Andrea D'Souza, Simon Gomberg, Paul Fields, David Wrench, Kavita Raj, Mary Gleeson, Kate Bailey, Richard Dillon, Matthew Streetly, Austin Kulasekararaj, Thinzar Ko Ko, Vallari Shah, Anne Rigg, Richard Sullivan, Mieke Van Hemelrijck, Saoirse Dolly |
114 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-04: COVID-19 disease in patients with lung cancer in Spain: GRAVID Lung Cancer Patients Disease (GRAVID study) |
Jose Maria Mazarico Gallego, Antonio Calles, Monica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, Ernest Nadal, et al. (+16) Rafael Lopez Castro, Ana Lopez-Martin, Edel del Barco, Manuel Domine, Virginia Calvo, Pilar Diz, Carmen Sandoval, Elia Sais Girona, Ivana Gabriela Sullivan, M. Angeles Sala, Gema Garcia Ledo, Jose Ramon Jarabo, Rosa Alvarez Alvarez, Javier Baena, Maria Gonzalez-Cao, Mariano Provencio |
115 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P06: Anticancer agent 3-deazauridine has the potential to be effective against COVID-19 due to its inhibition of replication of RNA viruses |
Richard Momparler |
116 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-06: Social Determinants of Health (SDOH) barriers as predictors of intent to vaccinate for COVID-19 in a vulnerable population |
Beth A. Jones, William Eger, Sakinah Suttiratana, Roy Herbst, Eiman Ibrahim, Hannah Behringer, Rachel A. Clare |
117 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-05: Prevalence of COVID-19 in asymptomatic cancer patients on active systemic treatment in a public Brazilian hospital: The impact of socioeconomic status |
Luiza Fadul, Barbara Benetton, Larissa Furlan, Marina Topanotti, Marcia Lanza, Mauricio Nogueira, et al. (+2) Aline Fares, Daniel Araujo |
118 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P11: The elevated level of the main markers of neutrophil extracellular traps in metastatic colorectal cancer plasma highlights the enhanced risk of severe forms of COVID-19 in cancer patients |
Alain R. Thierry, Brice Pastor, Jean-Daniel Abraham, Ekaterina Pisareva, Thibault Mazard |
119 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P33: Disparities in breast cancer screening and the impact of COVID-19 in Houston, Texas |
Maryam Nemati Shafaee, Luke Gilman, Abiodun Oluyomi, Melissa Bondy, Tamara Ortiz-Perez, Chris Amos, Mothaffar Rimawi |
120 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S06-03: Outcomes of COVID-19 in patients with cancer: Results of a prospective observational comparison of routine screening strategy versus testing based on clinical suspicion |
Zhuoer Xie, Antoine N. Saliba, Jithma Abeykoon, Umair Majeed, Daniel Almquist, Julia Wiedmeier-Nutor, et al. (+20) Evandro Bezerra, Xavier Andrade-Gonzalez, Ashley Hickman, Karl Sorenson, Sagar Rakshit, Christopher Wee, Sri Tella, Anuhya Kommalapati, Nadine Abdallah, Joshua Pritchett, Mariza De Andrade, Dipesh Uprety, Andrew Badley, Joleen Hubbard, Naseema Gangat, Carrie A. Thompson, Thomas Witzig, Robert R. McWilliams, Konstantinos Leventakos, Thorvardur R. Halfdanarson |
121 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S11-03: The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy’s Cancer Center |
Rushan Sylva, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Vallari Shah, et al. (+14) Thinzar Ko Ko, Tania Kalsi, Danielle Harari, Luigi De Michele, Shahram Kordasti, Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Andrea D'Souza, Simon Gomberg, Austin Kulasekararaj, Mieke Van Hemelrijck, Saoirse Dolly |
122 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P43: Clinical characteristics of COVID-19 infected cancer patients: A retrospective study in Royal Wolverhampton NHS Trust, United Kingdom |
Menna M. Fouda, Ankit Jain |
123 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P42: Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID-19 infection |
Jian He, Mei Meng, Yiyang Zhao |
124 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P28: COVID-19 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT): The Guy’s Cancer Centre experience |
Lucy Flanders, Beth Russell, Charlotte Moss, Kieran Palmer, Rushan Sylva, Gincy George, et al. (+14) Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Andrea D'Souza, Simon Gomberg, Richard Sullivan, Anne Rigg, Mieke Van Hemelrijck, Mark Harries, Irene De Francesco, Stephen Morris, Sophie Papa, Saiorse Dolly |
125 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-02: Comprehensive meta-analysis of COVID-19 mortality rates for 22 cancer subtypes from the Reboot: COVID-Cancer Project, an interactive resource with aggregated data from 21,839 cancer patients |
Emily-Claire Duffy, Kelly Fan, Shailesh Advani, Chris Bailey, James R.M. Black, Ellie Strauss, et al. (+9) Devon Crittenden, Thomas Bhangdia, Allyson Imbacuan, Emily Yang, Allison Britt, Pradeep Mangalath, Charles Swanton, Laura B. Kleiman, Catherine Del Vecchio Fitz |
126 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-01: Quantifying the impact of COVID-19 on cancer care: Pathology volume change in SEER cancer registries |
Todd Golden, Linda Coyle, Jennifer Stevens, Serban Negoita |
127 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P05: EpistoNet: An ensemble of deep convolutional neural networks using mixture of discriminative experts for detecting COVID-19 on chest X-ray images |
Seyed Ziae Mousavi Mojab, Seyedmohammad Shams, Farshad Fotouhi, Hamid Soltanian-Zadeh |
128 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P44: Factors affecting COVID-19 outcomes in cancer patients from Guy’s Cancer Center and King's College Hospital |
Kieran Palmer, Rushan Sylva, Beth Russell, Charlotte Moss, Vallari Shah, Thinzar Ko Ko, et al. (+22) Gincy George, Shahram Kordasti, Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Kamarul Zaki, Ailsa Sita-Lumsden, Debra Josephs, Deborah Enting, Angela Swampillai, Elinor Sawyer, Mary Lei, Andrea D’Souza, Simon Gomberg, Paul Fields, David Wrench, Richard Sullivan, Anne Rigg, Austin Kulasekararaj, Mieke Van Hemelrijck, Saoirse Dolly |
129 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S06-04: Telehealth experiences of adolescent and young adult cancer patients and survivors during the COVID-19 pandemic |
Karely Mann, Austin R. Waters, Perla L. Vaca Lopez, Echo L. Warner, Judy Ou, Heydon Kaddas, et al. (+9) Joemy Ramsay, Nicole Ray, Tomoko Tsukamoto, Douglas B. Fair, Joseph M. Letourneau, Mark A. Lewis, David Gill, Lauri Linder, Anne C. Kirchhoff |
130 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P40: PTSD and levels of general anxiety in Italian oncological patients during the COVID-19 pandemic |
Mariam Chichua, Eleonora Brivio, Serena Oliveri, Paolo Guiddi, Gabriella Pravettoni |
131 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S02-04: Drive By Flu-FIT: A novel way to mitigate the decrease in colorectal cancer screening during the COVID-19 pandemic |
Armenta Washington, Leroy Miles, Claudia Melendez, Brenda Bryant, Alexander Auchus, Michael Goldberg, et al. (+5) Scott Melnick, Juanita Way, Danielle Grant, Kimberly Highsmith, Carmen E. Guerra |
132 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S10-04: Disparities in food insecurity among cancer survivors during the U.S. COVID-19 pandemic |
Marlene Camacho-Rivera, Jessica Y. Islam, Denise C. Vidot |
133 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic |
Md Mohiuddin, Kazuo Kasahara |
134 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S04-02: Effects of demographic and behavioral factors on social isolation in a cancer center population during COVID-19 pandemic |
Cassandra A. Hathaway, Brian D. Gonzalez, Amanda Bloomer, Erin M. Siegel, Cornelia M. Ulrich, Anita R. Peoples, et al. (+2) Frank J. Penedo, Shelley S. Tworoger |
135 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P17: Effect of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic |
Vivek U. Nimgaonkar, Abigail T. Berman, Peter Gabriel, John Kucharczuk, Lawrence N. Shulman, Charu Aggarwal, Melina E. Marmarelis |
136 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S02-02: The impact of resuming the breast cancer screening program in the Netherlands on breast cancer incidence and stage after its discontinuation due to the COVID-19 pandemic |
Anouk H. Eijkelboom, Linda de Munck, Marc B.I. Lobbes, Jelle Wesseling, Carla H. van Gils, Pieter J. Westenend, et al. (+5) Cristina Guerrero Paez, Ruud M. Pijnappel, Helena M. Verkooijen, Mireille J.M. Broeders, Sabine Siesling |
137 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P36: Virtual cancer care in a tertiary care academic centre in Ireland during the COVID-19 pandemic - An analysis of physician and patient opinion |
Mary N. O'Reilly, Mark Doherty |
138 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S09-03: Real world data analysis of patients with genitourinary cancers receiving systemic anticancer treatment during the COVID-19 pandemic at Guy's Cancer Centre: A single centre retrospective study in the UK |
Christina Karampera, Beth Russell, Charlotte Moss, Rushan Sylva, Kieran Palmer, Elias Pintus, et al. (+6) Sarah Rudman, Debra Josephs, Kamarul Zaki, Mieke Van Hemelrijck, Saoirse Dolly, Deborah Enting |
139 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P19: Systemic anticancer treatment changes at the start of the COVID-19 pandemic in a large Australian metropolitan health service |
Elizabeth Liow, Cameron McLaren, Samuel Tipping-Smith, Sarah Latham, Jun Beng Kong, Marissa Lam, et al. (+4) Caroline Lum, Amy Body, Peter Briggs, Eva Segelov |
140 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P15: Treatment (TX) of advanced melanoma during the Coronavirus Disease 2019 (COVID-19) pandemic in Kaiser Permanente Northern California (KPNC) |
Juraj Kavecansky, Nina Shah, Angeles Price, Frank Hsieh, Alice Kengla, Belinda Ark, et al. (+12) Jahan Tavakoli, Christine Kaiser, Mingqing Li, Sejal Jhatakia, Mala Reddy, Dazhi Cen, Philip Sardar, Stephen Wang, Ashok Pai, Andrea Harzstark, Tatjana Kolevska, Thach-Giao Truong |
141 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S02-03: The impact of the COVID-19 pandemic on Barrett’s esophagus and esophago-gastric cancer |
Richard C. Turkington, Anita Lavery, David Donnelly, Anna T. Gavin, Damian T. McManus, Victoria Cairnduff, et al. (+4) Charlene M. McShane, Brian T. Johnston, Lesley A. Anderson, Helen G. Coleman |
142 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P45: A global snapshot of the impact of the COVID-19 pandemic on cancer research: Report from a Global Cancer and COVID-19 Task Force |
Louis Fox, Verna Vanderpuye, Richard Sullivan, Mieke Van Hemelrijck, Deborah Mukherji |
143 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S04-03: Impact of the COVID-19 pandemic on social and health behaviors among rural and urban cancer patients at Huntsman Cancer Institute (HCI) |
Bailee Daniels, Caroline Himbert, Cassandra A. Hathway, Tengda Lin, Karen Salas, Anjelica Ashworth, et al. (+22) Anne C. Kirchhoff, Anna Beck, Cindy Matsen, Courtney Scaife, Cristina Christenson, Douglas Grossman, Howard Colman, Jason P. Hunt, Jennifer Ose, Jonathan Tward, Kevin B. Jones, Michael Deininger, Mikaela Larson, Paul LaStayo, Thomas Varghese, Tracy Onega, Wallace L. Akerley, Frank J. Penedo, Erin M. Siegel, Cornelia M. Ulrich, Shelley S. Tworoger, Anita R. Peoples |
144 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P32: Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: A population-based study |
Ashleigh C. Hamilton, David W. Donnelly, Maurice B. Loughrey, Richard C. Turkington, Colin Fox, Deirdre Fitzpatrick, et al. (+3) Ciaran E. O'Neill, Anna T. Gavin, Helen G. Coleman |
145 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S10-02: Financial hardship and mental health among cancer survivors during the COVID-19 pandemic: An analysis of the U.S. COVID Impact Survey |
Jessica Y. Islam, Denise C. Vidot, Marlene Camacho-Rivera |
146 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P02: Predicting mortality in SARS-CoV-2 (COVID-19) positive patients in the inpatient setting using a Novel Deep Neural Network |
Fahad S. Ahmed, Maleeha Naseem, Hajra Arshad, Syeda Amrah Hashmi, Furqan Irfan |
147 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P26: Re-analyzing randomized trials with incorporation of COVID-19 risk associated with cancer therapy |
Shervin Tabrizi, Lorenzo Trippa, Daniel Cagney, Ayal A. Aizer, Shyam Tanguturi, Steffen Ventz, et al. (+8) Geoffrey Fell, Jennifer R. Bellon, Harvey Mamon, Paul Nguyen, Anthony V. D'Amico, Daphne Haas-Kogan, Brian M. Alexander, Rifaquat Rahman |
148 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P04: Effects of COVID-19 treatments on cancer: A machine learning approach to synthesize clinical evidence at scale |
Allison Britt, Emily Yang, Devon Crittenden, Thomas Bhangdia, Ben Nye, Emily-Claire Duffy, et al. (+15) Saradha Miriyala, Emily van der Veen, Sam Marchant, Kelly Fan, Ellie Strauss, Katherine McKinley, Kriti Sharda, Murshea Tuor, Ishita Mahajan, Noopur Ranganathan, Lailoo Perriello, Byron Wallace, Pradeep Mangalath, Laura B. Kleiman, Catherine Del Vecchio Fitz |
149 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S05-02: Plant viral nanoparticle-based adjuvants for cancer immunotherapy and COVID-19 vaccines |
Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, P. Jack Hoopes, Sourabh Shukla, Oscar A. Ortega-Rivera, et al. (+2) Steven King, Cyril J. Empig |
150 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P38: An examination of COVID-19-related preventive behaviors by cancer status |
Carrie A. Miller, Jeanine P.D. Guidry, Bernard F. Fuemmeler |
151 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P34: Health care disparities and outcomes of cancer patients with COVID-19: A pooled analysis of two Brazilian tertiary centers |
Marina Topanotti, Larissa L. Furlan, Catarina Marchon, Pedro Amaral, Barbara C. Beneton, Luiza A. Fadul, et al. (+5) Maria Lucia Salomao, Suzana M. Lobo, Aline F. Fares, Daniel V. Araújo, Eliza D. Ricardo |
152 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P18: Radical cancer treatment is safe during COVID-19: The experience of a large London-based Comprehensive Cancer Centre |
Beth Russell, Victoria Harris, Harvey Dickinson, Charlotte Moss, Graham Roberts, Kate Haire, et al. (+15) Eirini Tsotra, Harris Gousis, Debra Josephs, Deborah Enting, Ailsa Sita-Lumsden, Jose Roca, Vasilliki Michalaera, Mary Lei, Angela Swampillai, Eleanor Sawyer, Daniel Smith, Irene De Francesco, Teresa Guerrero-Urbano, Mieke Van Hemelrijck, Saoirse Dolly |
153 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P20: Continuity of oncology clinical trials during the Coronavirus Disease-2019 pandemic in Korea |
Hee Kyung Ahn, Soohyeon Lee, Seon-A Jang, Ji-Yeon Kim, Jin Seok Ahn, Yeon Hee Park |
154 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S03-04: Spatial profiling of lung SARS-CoV-2 and influenza virus infection identifies virus specific host responses and gene signatures |
Arutha Kulasinghe |
155 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P21: Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test |
Qing Sun, Jonathan Li, Hui Ren, Larry Pastor, Yulia Loginova, Joseph Wong, et al. (+4) Zhao Zhang, Aiguo Zhang, Chuanyi Mark Lu, Michael Sha |
156 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S03-02: Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study |
Lewis Au, Annika Fendler, Laura Amanda Boos, Fiona Byrnes, Scott Shepherd, Emma Nicholson, et al. (+9) Scaheen Kumar, Nadia Yousaf, Katalin Wilkinson, Anthony Swerdlow, Ruth Harvey, George Kassiotis, Robert Wilkinson, James Larkin, Samra Turajlic |
157 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection |
Michael Chiorazzi, Erin Silva, Kristina Brower, Patrick Wong, Carolina Lucas, Jon Klein, et al. (+25) Feimei Liu, Maura Nakahata, Jun Zhao, Nur-Taz Rahman, Camila Odio, Santos Bermejo, Shelli F. Farhadian, Charles Dela Cruz, Arnau Casanovas-Massana, John Fournier, Catherine Muenker, Anne L. Wyllie, Chantal B.F. Vogels, Chaney C. Kalinich, Mary E. Petrone, Isabel M. Ott, Anne E. Watkins, Adam J. Moore, Tara Alpert, Yuval Kluger, Aaron Ring, Nathan D. Grubaugh, Akiko Iwasaki, Albert I. Ko, Roy S. Herbst |
158 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score |
Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44) Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher C. T. Sng, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Ricard Mesia, Ailsa Sita-Lumsden, Elia Seguí, Federica Biello, Daniele Generali, Salvatore Grisanti, Pavetha Seeva, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Charlotte Moss, Beth Russell, Josep Tabernero, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Andrea Marrari, M. Carmen Carmona-García, Neha Chopra, Carlo Tondini, Oriol Mirallas, Valeria Tovazzi, Vittoria Fotia, Claudia A. Cruz, Nadia Saoudi-Gonzalez, Eudald Felip, Lorenza Scotti, Alvin J. X. Lee, Thomas Newsom-Davis, Andrea Patriarca, Lorenza Rimassa, Armando Santoro, Alessandra Gennari, Mieke Van Hemelrijck, Nikolaos Diamantis, David J. Pinato |
159 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S01-02: Assessing vulnerability of patients with lung cancer to SARS-CoV-2 infection based on serological antibody analyses |
Amy C. Moore, Paul A Bunn, Beatriz Fontoura, Adolfo García-Sastre, Jorge Gomez, Florian Krammer, et al. (+6) Phillip Mack, John D. Minna, Christian Rolfo, Yu Shyr, Peter Ujhazy, Fred R. Hirsch |
160 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P35: Targeting vimentin impacts multiple cellular processes, blocks the spike protein-ACE2-mediated pseudoviral infection in vitro and reduces the symptom and lung injury in aged mice with mouse-adapted SARS-CoV-2 infection in vivo |
Zhizhen Li, Jianping Wu, Baoshi Yuan, Kenneth Dinnon, Lian Mo, Fei Zhou, et al. (+6) Yingying Dong, Kendra Gully, Ralph Baric, Rachel Graham, Ying Xu, Ruihuan Chen |
161 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P13: Prospective voluntary SARS-CoV-2 virus and anti-COVID-19 antibody tests in asymptomatic medical and research staff who work in direct contact with cancer patients: A single center study |
Weijing Sun, Andrew K. Godwin, Kathan Mehta, Natalie Streeter, Elizabeth Wulff-Burchfield, Anup Kasi, et al. (+8) Tara L. Lin, Joaquina Baranda, Joseph McGuirk, Ziyan Pessetto, Adam Pessetto, B.J. Broome, Terry Tsue, Roy Jensen |
162 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P29: Pre-COVID-19 pandemic vs. post-COVID-19 pandemic: Sustained participation of minorities in research in a CAP accredited biorepository in UC San Diego, California |
Sharmeela A. Kaushal, David Anjakos, Mason A. Kyle, Diana Cortez-Moreno, Alfredo A. Molinolo |
163 |
[GO] |
Clinical Cancer Research |
2021―Mar―01 |
Vascular normalization to improve treatment of COVID-19: Lessons from treatment of cancer |
Lance L Munn, Triantafyllos Stylianopoulos, Natalie K Jain, C Corey Hardin, Melin J Khandekar, Rakesh K. Jain |
164 |
[GO] |
Cancer Discovery |
2021―Feb―26 |
COVID-19 Prolonged in Patients with Cancer |
|
165 |
[GO] |
Cancer Prevention Research |
2021―Feb―24 |
COVID-19 disruptions to endoscopic surveillance in Lynch syndrome |
Danielle B McKenna, Christina M Dudzik, Shria Kumar, Nadim Mahmud, Bryson W Katona |
166 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Feb―05 |
Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling? |
Anita W.W. Lim |
167 |
[GO] |
Clinical Cancer Research |
2021―Feb―04 |
How did we get a COVID-19 vaccine in less than one year? |
E. John Wherry, Elizabeth M. Jaffee, Nicholas Warren, Gypsyamber D'Souza, Antoni Ribas |
168 |
[GO] |
Cancer Discovery |
2021―Feb―02 |
Correction: Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers |
|
169 |
[GO] |
Cancer Immunology Research |
2021―Jan―15 |
At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer |
Antoni Ribas, Marina Chiara Garassino |
170 |
[GO] |
Blood Cancer Discovery |
2021―Jan―13 |
Cancer and COVID-19: On the Quest for Effective Vaccines |
Marwan Kwok, Edward F. Fritsch, Catherine J. Wu |
171 |
[GO] |
Cancer Discovery |
2020―Dec―30 |
Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection |
|
172 |
[GO] |
Cancer Research |
2020―Dec―22 |
Is COVID-19 - induced platelet activation a cause of concern for cancer patients? |
Lenard M. Lichtenberger, K. Vinod Vijayan |
173 |
[GO] |
Cancer Discovery |
2020―Dec―22 |
Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited |
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, Sayyed Kaleem Zaidi, Katie M Campbell, John M. Carethers, et al. (+4) Elizabeth M. Jaffee, E. John Wherry, Jean-Charles Soria, Gypsyamber D'Souza |
174 |
[GO] |
Cancer Discovery |
2020―Dec―22 |
As Pandemic Continues, Screening Concerns Grow |
|
175 |
[GO] |
Molecular Cancer Research |
2020―Dec―16 |
Relevance of the Bruton Tyrosine Kinase (BTK) as a target for COVID-19 therapy |
Miran Rada, Zahraa Qusairy, Marta Massip-Salcedo, Salvador Macip |
176 |
[GO] |
Cancer Discovery |
2020―Dec―11 |
Survival Factors ID'd for Patients with Blood Cancer + COVID-19 |
|
177 |
[GO] |
Blood Cancer Discovery |
2020―Nov―04 |
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers |
Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, et al. (+24) Sydney X. Lu, Sham Mailankody, Urvi A. Shah, Alexander M. Lesokhin, Hani Hassoun, Carlyn Tan, Francesco Maura, Andriy Derkach, Benjamin Diamond, Adriana Rossi, Roger Pearse, Deepu Madduri, Ajai Chari, David Kaminetzky, Marc J. Braunstein, Christian Gordillo, Ran Reshef, Ying Taur, Faith E. Davies, Sundar Jagannath, Ruben Niesvizky, Suzanne Lentzsch, Gareth J. Morgan, Ola Landgren |
178 |
[GO] |
Blood Cancer Discovery |
2020―Nov―02 |
Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19 |
Madhav V. Dhodapkar, Kavita M. Dhodapkar, Rafi Ahmed |
179 |
[GO] |
Clinical Cancer Research |
2020―Oct―13 |
Similarities in Risk for COVID-19 and Cancer Disparities |
Lisa Newman, Robert A Winn, John M. Carethers |
180 |
[GO] |
Blood Cancer Discovery |
2020―Oct―13 |
Don't Compromise Myeloma Care Due to COVID-19 Pandemic! |
Nikhil C. Munshi, Kenneth C. Anderson |
181 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Sep―25 |
Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: an analysis of the COVID-19 Impact Survey |
Jessica Y Islam, Marlene Camacho-Rivera, Denise C. Vidot |
182 |
[GO] |
Cancer Prevention Research |
2020―Sep―21 |
COVID-19, Cancer Care and Prevention |
Raymond N. DuBois |
183 |
[GO] |
Cancer Discovery |
2020―Sep―18 |
Repurposing Cancer Drugs for COVID-19 |
|
184 |
[GO] |
Cancer Prevention Research |
2020―Sep―17 |
Disparities in Cancer Prevention in the COVID-19 Era |
John M. Carethers, Rajarshi Sengupta, Rea Blakey, Antoni Ribas, Gypsyamber D'Souza |
185 |
[GO] |
Cancer Discovery |
2020―Sep―16 |
Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers |
|
186 |
[GO] |
Cancer Discovery |
2020―Sep―01 |
COVID-19 Challenges Status Quo for Cancer Care |
|
187 |
[GO] |
Cancer Discovery |
2020―Aug―19 |
ICI Impact on COVID-19 Severity Modest at Best |
|
188 |
[GO] |
Clinical Cancer Research |
2020―Aug―18 |
The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts |
Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric Lipp, Aaron C Tan, et al. (+3) David M Ashley, Kyle M Walsh, Mustafa Khasraw |
189 |
[GO] |
Blood Cancer Discovery |
2020―Jul―31 |
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers |
Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, Dhwani Patel, Eric L Smith, Neha Korde, et al. (+24) Sydney X Lu, Sham Mailankody, Urvi A. Shah, Alexander M Lesokhin, Hani Hassoun, Carlyn Tan, Francesco Maura, Andriy Derkach, Benjamin Diamond, Adriana Rossi, Roger Pearse, Deepu Madduri, Ajai Chari, David Kaminetzky, Marc J Braunstein, Christian Gordillo, Ran Reshef, Ying Taur, Faith E Davies, Sundar Jagannath, Ruben Niesvizky, Suzanne Lentzsch, Gareth J Morgan, Ola Landgren |
190 |
[GO] |
Cancer Discovery |
2020―Jul―31 |
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. |
David J Pinato, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher CT Sng, Ramon Salazar, et al. (+58) Alexia Bertuzzi, Joan Brunet, Ricard Mesía, Elia Seguì, Federica Biello, Daniele Generali, Salvatore Grisanti, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Anna Carbó, Riccardo Bruna, Sarah Benafif, Andrea Marrari, Rachel Wuerstlein, Maria Carmen Carmona-Garcia, Neha Chopra, Carlo Alberto Tondini, Oriol Mirallas, Valeria Tovazzi, Marta Betti, Salvatore Provenzano, Vittoria Fotia, Claudia Andrea Cruz, Alessia Dalla Pria, Francesca D'Avanzo, Joanne S Evans, Nadia Saoudi-Gonzalez, Eudald Felip, Myria Galazi, Isabel Garcia-Fructuoso, Alvin J X Lee, Thomas Newsom-Davis, Andrea Patriarca, David García-Illescas, Roxana Reyes, Palma Dileo, Rachel Sharkey, Yien Ning Sophia Wong, Daniela Ferrante, Javier Marco-Hernández, Anna Sureda, Clara Maluquer, Isabel Ruiz-Camps, Gianluca Gaidano, Lorenza Rimassa, Lorenzo Chiudinelli, Macarena Izuzquiza, Alba Cabirta, Michela Franchi, Armando Santoro, Aleix Prat, Josep Tabernero, Alessandra Gennari |
191 |
[GO] |
Cancer Discovery |
2020―Jul―22 |
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study |
Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M. Kuderer, Chih-Yuan Hsu, et al. (+39) Samuel M. Rubinstein, Brendan J Lee, Toni K Choueiri, Gilberto de Lima Lopes, Petros Grivas, Corrie A Painter, Brian I. Rini, Michael A. Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B Doroshow, Pamela C. Egan, Dimitrios Farmakiotis, Leslie Anne Fecher, Christopher R Friese, Matthew D Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R. Halfdanarson, Balazs Halmos, Jessica E Hawley, Ali Raza Khaki, Christopher A. Lemmon, Sanjay Mishra, Adam J Olszewski, Nathan A Pennell, Matthew M. Puc, Sanjay G. Revankar, Lidia Schapira, Andrew Schmidt, Gary K. Schwartz, Sumit A Shah, Julie T Wu, Zhuoer Xie, Albert C. Yeh, Huili Zhu, Yu Shyr, Gary H. Lyman, Jeremy L Warner |
192 |
[GO] |
Cancer Discovery |
2020―Jul―15 |
Cancer Research: The lessons to learn from COVID-19 |
Chris Bailey, James R M Black, Charles Swanton |
193 |
[GO] |
Clinical Cancer Research |
2020―Jul―02 |
COVID-19 testing in cancer patients: Does one size fit all? |
Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei-Fei Liu, Camilla Zimmermann, et al. (+3) Shahid Husain, Gelareh Zadeh, Amit M Oza |
194 |
[GO] |
Clinical Cancer Research |
2020―Jun―15 |
Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era |
Michele Maio, Omid Hamid, James Larkin, Alessia Covre, Maresa Altomonte, Luana Calabrò, et al. (+6) Santosha A Vardana, Caroline Robert, Ramy Ibrahim, Andrea Anichini, Jedd D. Wolchok, Anna Maria Di Giacomo |
195 |
[GO] |
Cancer Discovery |
2020―Jun―08 |
COVID-19 Delays Cancer Screenings |
|
196 |
[GO] |
Clinical Cancer Research |
2020―Jun―05 |
The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic. |
Fatima Karzai, Ravi A. Madan, William Dahut |
197 |
[GO] |
Cancer Discovery |
2020―May―29 |
Registries Offer Insights on COVID-19-Cancer Connection |
|
198 |
[GO] |
Cancer Discovery |
2020―May―22 |
The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 |
Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, Mehdi Bouhaddou, Manon Eckhardt, David E Gordon, Nevan J Krogan |
199 |
[GO] |
Cancer Discovery |
2020―May―13 |
The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research |
Tobias Janowitz, David A. Tuveson |
200 |
[GO] |
Cancer Discovery |
2020―May―12 |
Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers |
Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann |
201 |
[GO] |
Cancer Discovery |
2020―May―05 |
Cytokine Storm Drugs Move from CAR T to COVID-19 |
|
202 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―May―05 |
The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action |
Andrew T. Chan, David A. Drew, Long H. Nguyen, Amit D. Joshi, Wenjie Ma, Chuan-Guo Guo, et al. (+54) Chun-Han Lo, Raaj S. Mehta, SOHEE KWON, Daniel R. Sikavi, Marina V. Magicheva-Gupta, Zahra S. Fatehi, Jacqueline J. Flynn, Brianna M. Leonardo, Christine M. Albert, Gabriella Andreotti, Laura E. Beane Freeman, Bijal A. Balasubramanian, John S Brownstein, Fiona Bruinsma, Annie N. Cowan, Anusila Deka, Michael E. Ernst, Jane C. Figueiredo, Paul W. Franks, Christopher D Gardner, Irene M. Ghobrial, Christopher A. Haiman, Janet E. Hall, Sandra L. Deming-Halverson, Brenda Kirpach, James V Lacey, Loic Le Marchand, Catherine R. Marinac, Maria Elena Martinez, Roger L. Milne, Anne M Murray, Denis Nash, Julie R. Palmer, Alpa V. Patel, Lynn Rosenberg, Dale P. Sandler, Shreela V Sharma, Shepherd H. Schurman, Lynne R. Wilkens, Jorge E. Chavarro, A. Heather Eliassen, Jaime E. Hart, Jae Hee Kang, Karestan C. Koenen, Laura D. Kubzansky, Lorelei A. Mucci, Sebastien Ourselin, Janet W. Rich-Edwards, Mingyang Song, Meir J Stampfer, Claire J. Steves, Walter C. Willett, Jonathan Wolf, Tim Spector |
203 |
[GO] |
Cancer Discovery |
2020―May―01 |
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System |
Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Daniel Cole, Mendel Goldfinger, Ana Acuna-Villaorduna, et al. (+13) Kith Pradhan, Raja Thota, Stan Reissman, Joseph A. Sparano, Benjamin A Gartrell, Richard V. Smith, Nitin Ohri, Madhur Garg, Andrew D. Racine, Shalom Kalnicki, Roman Perez-Soler, Balazs Halmos, Amit Verma |
204 |
[GO] |
Cancer Discovery |
2020―Apr―28 |
Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak |
Mengyuan Dai, Dianbo Liu, Miao Liu, Fuxiang Zhou, Guiling Li, Zhen Chen, et al. (+32) Zhian Zhang, Hua You, Meng Wu, Qichao Zheng, Yong Xiong, Huihua Xiong, Chun Wang, Changchun Chen, Fei Xiong, Yan Zhang, Yaqin Peng, Siping Ge, Bo Zhen, Tingting Yu, Ling Wang, Hua Wang, Yu Liu, Yeshan Chen, Junhua Mei, Xiaojia Gao, Zhuyan Li, Lijuan Gan, Can He, Zhen Li, Yuying Shi, Yuwen Qi, Jing Yang, Daniel G Tenen, Li Chai, Lorelei A. Mucci, Mauricio Santillana, Hongbing Cai |
205 |
[GO] |
Cancer Discovery |
2020―Apr―24 |
COVID-19 Hits Cancer Research Funding |
|
206 |
[GO] |
Cancer Discovery |
2020―Apr―20 |
COVID-19 More Frequent, Severe in Cancer Patients |
|
207 |
[GO] |
Clinical Cancer Research |
2020―Apr―20 |
Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic |
Aaron C Tan, David M Ashley, Mustafa Khasraw |
208 |
[GO] |
Cancer Discovery |
2020―Apr―17 |
Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients |
Sangya Agarwal, Carl H. June |
209 |
[GO] |
Cancer Discovery |
2020―Apr―15 |
AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic |
|
210 |
[GO] |
Cancer Discovery |
2020―Apr―10 |
Cancer Care Goes Virtual in Response to COVID-19 |
|
211 |
[GO] |
Cancer Discovery |
2020―Apr―10 |
TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? |
Konrad H. Stopsack, Lorelei A. Mucci, Emmanuel S. Antonarakis, Peter S. Nelson, Philip W. Kantoff |
212 |
[GO] |
Cancer Discovery |
2020―Apr―01 |
Clinical Research Slows as COVID-19 Surges |
|
213 |
[GO] |
Cancer Discovery |
2020―Mar―31 |
Cancer Labs Pivot to Battle COVID-19 |
|
214 |
[GO] |
Cancer Discovery |
2020―Mar―24 |
COVID-19 Challenges Basic Researchers |
|
|